Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/24/2017 04/25/2017 04/26/2017 04/27/2017 04/28/2017 Date
25.56(c) 25.74(c) 25.97(c) 26.18(c) 26.38(c) Last
14 799 478 10 268 045 9 479 935 12 027 348 9 021 606 Volume
+2.82% +0.70% +0.89% +0.81% +0.76% Change
More quotes
Financials ($)
Sales 2017 8 866 M
EBIT 2017 2 066 M
Net income 2017 1 373 M
Debt 2017 4 412 M
Yield 2017 -
Sales 2018 9 473 M
EBIT 2018 2 345 M
Net income 2018 1 609 M
Debt 2018 3 177 M
Yield 2018 -
P/E ratio 2017 28,44
P/E ratio 2018 24,00
EV / Sales2017 4,57x
EV / Sales2018 4,15x
Capitalization 36 113 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.Its products and technologies are used to diagnose or treat medical conditions, including heart, digestive, pulmonary, vascular, urological, women's... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
04/28 INSIDER TRADING ACTIVITY BOSTON SCIE : BSX) – EVP Sold 34,773 shares of St..
04/28 INSIDER TRADING ACTIVITY BOSTON SCIE : BSX) – SVP Sold 10,250 shares of St..
04/27 BOSTON SCIENTIFIC : sales leap 10 percent, but profit misses expectations
04/27 BOSTON SCIENTIFIC CO. (NYSE : BSX) reported earnings of $0.29 per share missing ..
04/27 BOSTON SCIENTIFIC : Contract award - 65-- icd-boston scientific
04/27 BOSTON SCIENTIFIC : $26,000 Federal Contract Awarded to Boston Scientific
04/27 BOSTON SCIENTIFIC CORPORATION (NYSE : BSX) Files An 8-K Results of Operations an..
04/27 BOSTON SCIENTIFIC CORP : Results of Operations and Financial Condition, Financia..
04/27 BOSTON SCIENTIFIC : profit jumps, but falls short of forecasts
04/27 BOSTON SCIENTIFIC : Announces Results For First Quarter 2017
More news
Sector news : Advanced Medical Equipment & Technology - NEC
04/24DJPHILIPS : Net Profit Leaps; Backs Full Year Guidance
04/10DJCorrections & Amplifications -- WSJ
03/28DJPHILIPS : to Buy Australian pharmacy Sleep Services Firm
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
2012All technical elements to short
More Strategies
Latest Tweets
04/29Boston Scientific $BSX Earning Favorable News Coverage, Analysis Shows  
04/28Boston Scientific's buy rating reiterated at Stifel Nicolaus. $30.00 PT.  
04/28Boston Scientific Co. $BSX Issues FY17 Earnings Guidance  
04/28RECAP 4/28 Unusual Calls: $BSX $CL $MSCC $BKD $WYN $OSTK $SBUX $SWN $EWY $ORC..
2
04/28Boston Scientific's outperform rating reiterated at Cowen and Company. $31.00.. 
More tweets
Qtime:135
News from SeekingAlpha
04/27 Boston Scientific (BSX) Q1 2017 Results - Earnings Call Transcript
04/27 Boston Scientific Q1 top line up 10%; earnings up 44%, revenue guidance raise..
04/27 Boston Scientific misses by $0.01, beats on revenue
04/26 Notable earnings before Thursday?s open
04/25 The Return Of Medtech Scale-Building?
Advertisement
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 29,3 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian Meredith Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORP..21.96%36 113
THERMO FISHER SCIENTIF..17.17%64 680
DANAHER CORPORATION7.05%57 841
PHILIPS9.72%32 224
INTUITIVE SURGICAL, IN..31.81%30 794
ILLUMINA, INC.44.38%27 045
More Results